Genetic testing to help diagnose liver transplant rejection
Part of Immune system & allergy clinical trials.
This study looks at whether genetic testing of a tissue sample (biopsy) can help doctors more accurately diagnose rejection after a liver transplant. It is for people who have already been diagnosed with rejection and have a stored tissue sample available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with rejection after a liver transplant
- A tissue sample from that rejection is available for additional testing (RT-PCR)
- You are 18 years of age or older
- You are willing and able to provide informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at liver tissue before transplantation to find ways to predict how well the transplant will work. It involves a special treatment called HOPE to help preserve the liver.
This study looks at how special lab tests from tiny tissue samples (microarrays) could help guide diagnosis and treatment in people who receive a liver transplant. It may help doctors better understand what’s going on and choose care more accurately.
This study looks at the genes in kidney biopsy tissue from children and young adults who have had a kidney transplant. Researchers want to find genetic markers that could help detect transplant rejection earlier, which might help doctors tailor treatment.
This study looks at using a special lab test (microarrays) on tissue taken during a lung transplant biopsy. It aims to learn how the test may help doctors better diagnose and guide care after transplant.
This study looks at how well noninvasive tests (tests that don’t require surgery or taking tissue) can detect complications after a liver transplant. It may help patients and teams find problems earlier using safer, easier monitoring.
This study checks whether a special blood test can predict who is at higher risk of graft loss (the transplanted liver not working well) and death after a liver transplant. It may help doctors identify higher-risk patients earlier and tailor follow-up care.
Hear when a new Rejection; Transplant, Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.